SKILLED, CARING PROFESSIONALS

LATISSE®

LATISSE® (bimatoprost ophthalmic solution) 0.03% is a prescription-strength eyelash growth serum that is FDA approved.  Latisse® has been proven to increase the growth, length, thickness, and darkness of eyelashes with regular and consistent use.  

Visible improvement in the appearance of the eyelashes will occur gradually. In the clinical trial leading to FDA approval, the majority of Latisse users saw a significant improvement in eyelashes within 2 months, with the optimum improvement occurring after 4 months of use.  

Please note:  Individual Results May Vary.  

LATISSE® Before & After Photos

Frequently Asked Questions

What is LATISSE®?

LATISSE® solution, a prescription treatment for hypotrichosis, promotes the growth of eyelashes, making them longer, thicker and darker. Hypotrichosis is another name for having inadequate or not enough eyelashes.

How does LATISSE® work?

LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase; and second, it increases the number of hairs in this growth phase. The exact way it works is unknown.

Could Latisse darken my eyelids?

Skin hyperpigmention (or skin darkening) is a less common side effect, which typically occurs close to where the solution is applied on the skin. This is due to an increase of melanin in the skin. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible in most patients upon discontinuation of bimatoprost. Skin hyperpigmention (or skin darkening) is a less common side effect, which typically occurs close to where the solution is applied on the skin. This is due to an increase of melanin in the skin. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible in most patients upon discontinuation of bimatoprost.

Could LATISSE® cause the color of my eyes to change?

Increased brown iris pigmentation has occurred when the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure. Although iris pigmentation was not reported in clinical studies with LATISSE®, patients should be advised about the potential for increased brown iris pigmentation which is likely permanent.

Are there any possible side effects?

Throughout clinical trials, some users did experience itchy eyes and eye redness. However, some users found that these irritations went away once they became accustomed to the product or began applying it properly. Skin hyperpigmention (or skin darkening) is a less common side effect, which typically occurs close to where the solution is applied on the skin. This is due to an increase of melanin in the skin. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible in most patients upon discontinuation of bimatoprost. Increased brown iris pigmentation has occurred when the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure. Although iris pigmentation was not reported in clinical studies with LATISSE®, patients should be advised about the potential for increased brown iris pigmentation which is likely permanent.

How long do the results last?

To maintain effect, continued treatment with LATISSE® is required. If use of LATISSE® is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

How soon will results appear?

LATISSE® users can expect to experience longer, fuller and darker eyelashes in as little as 8 weeks, with full results in 16 weeks.

Important Information

Indication

LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness

Important Safety Information

Contraindications: LATISSE® is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients.

Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible upon discontinuation of bimatoprost in most patients.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.

LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.

Adverse Reactions: The most frequently reported adverse reactions were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. These reactions occurred in less than 4% of patients.

Postmarketing Experience: The following adverse reactions have been identified during postapproval use of LATISSE®: dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema, hordeolum, hypersensitivity (local allergic reactions), lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), periorbital and lid changes associated with a deepening of the eyelid sulcus, rash (including macular and erythematous), skin discoloration (periorbital), trichiasis, and vision blurred.

Please see LATISSE® full Prescribing Information

Buy LATISSE in our spa or schedule a Virtual Consultation and BUY ONLINE with FREE 2-Day shipping.

Call us for more information (203) 884-8077
Skip to content